Ferric Citrate

Auryxia Coupons & Discount Card - Compare Prices Near You

ferric citrate

Ferric citrate, marketed as Auryxia, is a medication used to manage high phosphate levels in adults with chronic kidney disease on dialysis, as well as to address iron-deficiency anemia in those with chronic kidney disease not on dialysis. This drug functions as a phosphate binder by attaching to the phosphorus in the food you consume, preventing its absorption into the bloodstream and aiding its elimination through waste. By reducing phosphate levels, it helps protect bones and reduce the risk of mineral buildup that can lead to heart disease and strokes. Additionally, ferric citrate serves as an iron supplement, essential for producing red blood cells and maintaining overall health. It is available in 210 mg tablets, taken orally three times daily with meals. Common side effects include dark stools, diarrhea, and constipation. Always consult your healthcare provider for personalized medical advice before starting any new medication.
Our Auryxia coupons are free to use. You can print the coupon, email it to yourself, or receive the Auryxia coupon via text message. To get your free discount, show the pharmacist your Auryxia savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Auryxia prices will update based on your prescription needs. Above our Auryxia coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Auryxia savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

1 GM210 MG(Fe), Ferric Citrate (30 Tablets)

Select pharmacy

Pharmacy logo

CVS

$132.03

COUPON PRICE
Pharmacy logo

Walmart

$209.98

COUPON PRICE
Pharmacy logo

Walgreens

$220.97

COUPON PRICE

Auryxia savings card

Show this card to your pharmacist
Pharmacy logo

CVS

$132.03

BIN

ID

PCN

GRP

019876

LHD298DC8D

CHIPPO

LHX

Powered by

This card is not insurance

Related phosphate binders prescriptions

coupons from$32.46Save 87%
coupons from$511.87Save 73%
coupons from$9.34Save 91%
coupons from$61.74Save 84%
coupons from$160.87Save 43%

More prescriptions for hyperphosphatemia

coupons from$160.87Save 43%
coupons from$29.37Save 85%
coupons from$9.34Save 91%
coupons from$9.86 

Related phosphate binders prescriptions

Renagel Save 87%coupons from $32.46
Velphoro Save 73%coupons from $511.87
Renvela Save 91%coupons from $9.34
Fosrenol Save 84%coupons from $61.74
Phoslyra Save 43%coupons from $160.87

More prescriptions for hyperphosphatemia

Phoslyra Save 43%coupons from $160.87
Sevelamer Hcl Save 85%coupons from $29.37
Sevelamer Carbonate Save 91%coupons from $9.34
Calcium Acetatecoupons from $9.86

Auryxia dosage forms

The average cost for 30 Tablets of Auryxia (ferric citrate) at 1 GM210 MG(Fe) is $220.49 with a free coupon. This is 27.20% off the average retail price of $810.65
DosageQuantityPrice fromPer unit
1 GM210 MG(Fe)30 Tablets$220.49$7.35

Auryxia Warnings

This medication contains important safety information that should be carefully considered by all users. Below are the critical warnings and precautions associated with its use:

  • Iron Overdose Risks: Taking an excessive amount of medications or supplements containing iron, such as Auryxia (ferric citrate), can lead to elevated iron levels. This poses serious health risks, including potential damage to the liver, seizures, and gastrointestinal issues. Regular monitoring of iron levels through blood tests is essential while using this medication. Notify your healthcare provider immediately if you experience symptoms like nausea, vomiting, stomach pain, or diarrhea.

  • Accidental Overdose in Children: Products containing iron can be extremely dangerous if accidentally ingested by children under the age of six. Always keep Auryxia (ferric citrate) out of their reach. In case a child ingests this medication and exhibits symptoms such as vomiting blood, diarrhea, or stomach pain, seek medical assistance promptly or contact the Poison Control Center at 1-800-222-1222.

  • Contraindications: This medication should not be used by individuals with conditions that lead to high iron levels, such as hemochromatosis, as it may result in serious health complications. Consult your healthcare provider if you have any such conditions before starting this medication.

These guidelines are intended to ensure the safe use of this medication. Always follow your healthcare provider's instructions and inform them of any concerns or symptoms you may experience.

Auryxia Side Effects

When taking this medication, some common side effects may include nausea, diarrhea, constipation, or vomiting. These are generally mild and tend to resolve on their own, but if they persist or worsen, it's important to consult your healthcare provider. Another common effect is black or dark stools due to the iron content, which is harmless and should not be a cause for concern.

There are also other side effects that might occur, such as stomach pain, cough, or elevated potassium levels in the blood. Although these are less common, they should be monitored, and medical advice sought if they are bothersome.

In rare cases, serious side effects can occur, requiring immediate medical attention. A severe allergic reaction, characterized by rash, itching, swelling of the face, tongue, or throat, severe dizziness, and difficulty breathing, is one such example. Another serious concern is iron overdose, which can present with symptoms like extreme nausea and vomiting, pale or bluish skin, abdominal pain, tarry stools, seizures, extreme drowsiness, or even coma. If any of these symptoms arise, it is crucial to seek urgent medical help.

Auryxia Interactions

Ferric Citrate can interfere with your body’s ability to absorb various medications. This includes drugs like bisphosphonates (e.g., Alendronate), certain quinolone antibiotics (e.g., Ciprofloxacin), thyroid medications (e.g., Levothyroxine), and tetracycline antibiotics (e.g., doxycycline). To minimize this interaction, ensure you take these medications at different times than ferric citrate. Consult with your doctor or pharmacist to determine an appropriate time gap between doses and to help you create a suitable medication schedule.
Auryxia FAQs
What is auryxia used for?

Auryxia is used to treat hyperphosphatemia, which is an elevated level of phosphate in the blood, in patients with chronic kidney disease on dialysis. It is also used to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis.

Auryxia and sevelamer are not the same. Auryxia contains ferric citrate and is used to control serum phosphorus levels in patients with chronic kidney disease on dialysis, as well as to treat iron deficiency anemia in patients with chronic kidney disease not on dialysis. Sevelamer, on the other hand, is a phosphate binder used to control phosphorus levels in patients with chronic kidney disease on dialysis. They have different active ingredients and mechanisms of action.

Yes, Auryxia (ferric citrate) can cause black stools. This is a common side effect due to the iron content in the medication. If there are any concerns about this or other side effects, it is advisable to consult a healthcare professional.

An alternative to Auryxia (ferric citrate) for managing hyperphosphatemia in patients with chronic kidney disease on dialysis could be other phosphate binders such as sevelamer (Renvela or Renagel), lanthanum carbonate (Fosrenol), or calcium acetate (PhosLo). It is important for patients to consult with their healthcare provider to determine the most appropriate treatment option based on their specific medical condition and needs.

Yes, Auryxia is an iron-based medication used to manage phosphorus levels in patients with chronic kidney disease on dialysis. It also provides iron supplementation to help treat iron deficiency anemia in patients with chronic kidney disease not on dialysis.